NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » New injectables: technology meets biologic development

White Paper

New injectables: technology meets biologic development

January 8, 2019

SHL Group’s innovative technologies support highly viscous biologic formulations that are being developed to reduce the number of injections needed for patients. The company is a pioneer in injectables that use leading technology to increase safety and connectivity.

Download to find out more.

Download White Paper